Corporate insider profile
Michael A Metzger Insider Trades
Michael A Metzger has reported no open-market purchases on SEC Form 4 and is a net seller of $914,801 across 1 company. The most recent open-market transaction was reported on Jul 8, 2026. Source: SEC Form 4 filings.
Latest reported as Chief Executive Officer of Syndax Pharmaceuticals Inc (SNDX).
SEC-reported filing activity is provided for research purposes and is not investment advice.
- Purchase filings
- 0
- Reported companies
- 1
- Net open-market value
- -$914,801.01
- Latest transaction
- Jul 8, 2026
Affiliated corporations
Reported company relationships
Transaction history
Open-market Transactions
Common questions
Michael A Metzger insider trading FAQ
- Is Michael A Metzger buying or selling stock?
- Across all SEC Form 4 open-market filings on record, Michael A Metzger is a net seller of $914,801, with no open-market purchases reported. The latest transaction was reported on Jul 8, 2026.
- Which companies does Michael A Metzger report insider trades for?
- Michael A Metzger has reported open-market trades in Syndax Pharmaceuticals Inc (SNDX). The latest SEC-reported relationship is Chief Executive Officer of Syndax Pharmaceuticals Inc (SNDX).
- Where does Michael A Metzger's insider trading data come from?
- Watch Insiders reads the SEC Form 4 filings submitted to EDGAR under reporting owner CIK 1507220, and refreshes this page daily.
